Regarding radiotherapy, tumor hypoxia initiates pro-survival mitophagy, driving radioresistance (34), whereas blocking the PINK1/Parkin axis (35) or administering mitochondrial-targeted antioxidants (36) restores radiosensitivity. This evidence concerns the gene PRKN and neoplasm.